SP
BravenNow
Tirzepatide
🌐 Entity

Tirzepatide

Anti-diabetic and weight loss medication

📊 Rating

10 news mentions · 👍 0 likes · 👎 0 dislikes

📌 Topics

  • Pharmaceutical innovation (2)
  • Telehealth Expansion (1)
  • Weight Loss Pharmaceuticals (1)
  • Digital Healthcare Access (1)
  • Healthcare Disruption (1)
  • Corporate Partnership (1)
  • Supply Chain Innovation (1)
  • Clinical Trials (1)
  • Pharmaceutical Innovation (1)
  • Psoriatic Arthritis Treatment (1)
  • Combination Therapy (1)
  • Medical Research (1)

🏷️ Keywords

Eli Lilly (6) · Zepbound (5) · Taltz (3) · Mounjaro (3) · GLP-1 (2) · Psoriasis (2) · Combination therapy (2) · LifeMD (1) · weight loss drug (1) · telehealth (1) · obesity treatment (1) · digital health platform (1) · Amazon Pharmacy (1) · weight-loss drug (1) · same-day delivery (1) · pharmaceutical distribution (1) · GLP-1 agonist (1) · healthcare access (1) · Psoriatic Arthritis (1) · Phase 3b Trial (1)

📖 Key Information

Tirzepatide is an antidiabetic medication used to treat type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections (under the skin). In the United States, it is sold under the brand name Mounjaro for diabetes treatment and Zepbound for weight loss and treatment of obstructive sleep apnea.

📰 Related News (10)

🔗 Entity Intersection Graph

Eli Lilly(7)Ixekizumab(3)Psoriasis(2)Semaglutide(2)Combination therapy(1)Liraglutide(1)Weight loss(1)India(1)Aspen Pharmacare(1)Sahara(1)Tirzepatide

People and organizations frequently mentioned alongside Tirzepatide:

🔗 External Links